Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
Completed · Phase 2
Conditions studied: Psoriasis
In brief
A Phase 2, Multi-Center, Double-Blind, Randomized, Vehicle-Controlled Study.
Key facts
- Study ID
- NCT02785185
- Run by
- Bausch Health Americas, Inc.
- People needed
- 150
- Starts
- 2016-06-01
- Expected to finish
- 2017-01-01
- Last updated by the study team
- 2020-08-27
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: accepted.
Where it is running
- Valeant Site 05 — Rogers, Arkansas, United States
- Valeant Site 10 — Beverly Hills, California, United States
- Valeant Site 09 — Carlsbad, California, United States
- Valeant Site 13 — Los Angeles, California, United States
- Valeant Site 12 — Santa Monica, California, United States
- Valeant Site 07 — Coral Gables, Florida, United States
- Valeant Site 11 — North Miami Beach, Florida, United States
- Valeant Site 03 — Sanford, Florida, United States
- Valeant Site 08 — Albany, Indiana, United States
- Valeant Site 04 — Louisville, Kentucky, United States
- Valeant Site 06 — Fridley, Minnesota, United States
- Valeant Site 02 — High Point, North Carolina, United States
- Valeant Site 01 — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.